Home › Atrial Fibrillation › Georgia
Atrial Fibrillation clinical trials in Georgia
17 studies for Atrial Fibrillation are looking for participants at sites in Georgia.
Cities in Georgia
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- Emory University, Atlanta
- Georgia Arrhythmia Consultants and Research Institute, Warner Robins
RecruitingPhase 3
Ages 22 to 85 · All sexes · Updated Sep 30, 2026 · NCT05836987Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Grady Health System, Atlanta
- NSC Research, Inc, Johns Creek
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07175428Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Atlanta Clinical Research Centers, Atlanta
- NSC Research, Inc, Johns Creek
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07626411Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
- Emory Saint Joseph's Hospital, Atlanta
Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07575269PULSED AF Post-Approval Study
- Piedmont Heart Institute, Atlanta
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06578104Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Piedmont Healthcare, Atlanta
- Memorial Health University Medical Center, Savannah
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071The Fourth Left Atrial Appendage Occlusion Study
- Emory University, Atlanta
Recruiting
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05963698Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Atlanta Clinical Research Centers, Atlanta
- NSC Research, Inc, Johns Creek
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07430956Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- Piedmont Heart Institute, Atlanta
- Memorial Health University Medical Center, Savannah
Recruiting
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07298473Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Emory, Atlanta
- Northside Hospital, Atlanta
Recruiting
Ages 18 to 80 · All sexes · Updated Jul 15, 2026 · NCT06784466Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1033, Macon
- Anthos Investigative Site 1003, Suwanee
- Anthos Investigative Site 9953, Tucker
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200BoxX-NoAF Clinical Trial
- Emory University, Atlanta
- Piedmont Hospital, Atlanta
- Wellstar Health System, Marietta
RecruitingHealthy volunteers welcome
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT06989775Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Emory University, Atlanta
- Piedmont Healthcare Inc., Atlanta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT04045665Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
- Augusta University Medical Center, Augusta
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
- Piedmont Heart of Athens, Athens
- Piedmont Heart Institute, Atlanta
Recruiting
Ages 22 and older · All sexes · Updated Mar 16, 2026 · NCT06935591DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)
- Emory Clinic, Atlanta
RecruitingObservational study
Ages 55 and older · All sexes · Updated Jan 21, 2026 · NCT05795842The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
- Piedmont Healthcare, Atlanta
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 31, 2025 · NCT06324201From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.